Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $45.37 | -0.31% | 12.58% | 20.19% | 44.12% | 68.66% | 185.71% | 500.93% | 302.93% | 217.49% | $46.48 | $15.16 | 2.39% | 199.27% | 1.87 | 2,543,840 | -22.25% |
| AUPH | AURINIA PHARMACEUTICALS INC | $8.20 | -0.49% | 1.23% | 1.86% | 4.99% | 12.02% | 57.69% | -24.70% | -47.74% | 121.02% | $10.67 | $4.99 | 23.15% | 64.33% | 1.06 | 888,819 | -17.07% |
| CORT | CORCEPT THERAPEUTICS INC | $71.48 | -0.56% | -0.43% | -22.25% | 7.41% | 50.10% | 199.33% | 224.17% | 485.90% | 1,093.32% | $117.33 | $23.02 | 39.08% | 210.51% | 0.92 | 1,031,357 | 27.32% |
| KRYS | KRYSTAL BIOTECH INC | $165.69 | -2.47% | -2.03% | -5.09% | 4.19% | -6.07% | 3.77% | 160.31% | 257.78% | N/A | $219.34 | $141.72 | 24.46% | 16.91% | 1.34 | 257,506 | 22.07% |
| NAGE | NIAGEN BIOSCIENCE INC | $7.56 | -3.69% | 2.44% | 10.04% | 37.70% | 29.01% | 106.56% | 279.90% | 44.00% | 115.38% | $9.18 | $2.31 | 17.65% | 227.98% | 1.23 | 424,059 | 2.74% |
| SPRY | ARS PHARMACEUTICALS INC | $14.16 | 1.36% | -3.28% | 13.01% | 15.03% | -7.21% | 51.77% | 349.52% | N/A | N/A | $18.51 | $7.55 | 23.50% | 87.55% | 1.02 | 931,422 | -9.18% |
| GYRE | GYRE THERAPEUTICS INC | $9.34 | -4.30% | 2.41% | 45.71% | -19.27% | -35.45% | -32.61% | 31.88% | -88.96% | -99.75% | $19.00 | $6.11 | 50.84% | 52.86% | 1.13 | 110,820 | 31.56% |
| ARGX | ARGENX SE | $639.90 | -0.81% | 6.56% | 12.84% | -2.69% | 7.44% | 66.93% | 118.14% | 339.73% | N/A | $678.21 | $352.77 | 5.65% | 81.39% | 0.70 | 176,184 | -44.91% |
| CPRX | CATALYST PHARMACEUTICALS INC | $24.27 | -0.08% | 4.66% | 1.46% | 7.29% | 10.87% | 59.67% | 210.76% | 427.61% | 628.83% | $26.16 | $14.47 | 7.22% | 67.73% | 1.07 | 1,060,804 | 12.60% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.86 | 1.32% | 1.46% | -7.90% | -22.84% | -9.73% | -1.35% | -33.79% | N/A | N/A | $41.61 | $26.47 | 28.24% | 12.81% | 0.85 | 715,664 | 64.40% |
| VCEL | VERICEL CORP | $37.92 | -0.26% | -7.71% | -11.99% | -35.79% | -13.80% | -19.46% | 26.57% | 170.66% | 1,049.09% | $63.00 | $37.39 | 39.81% | 1.42% | 1.43 | 607,304 | 57.83% |
| EXEL | EXELIXIS INC | $38.89 | -0.66% | 4.51% | 6.87% | 18.28% | 13.98% | 77.38% | 71.62% | 61.37% | 1,274.20% | $40.02 | $20.14 | 2.82% | 93.10% | 0.62 | 2,455,084 | 14.14% |
| SRPT | SAREPTA THERAPEUTICS INC | $62.78 | 0.61% | 1.65% | 1.41% | -44.84% | -49.08% | -52.04% | -14.91% | -44.61% | 393.36% | $173.25 | $48.01 | 63.76% | 30.76% | 0.90 | 1,357,656 | -13.91% |
| HALO | HALOZYME THERAPEUTICS INC | $60.03 | -2.26% | 1.32% | -2.97% | 6.66% | 5.04% | 52.75% | 46.95% | 159.09% | 280.18% | $66.00 | $39.79 | 9.05% | 50.87% | 0.85 | 1,139,738 | -16.57% |
| RIGL | RIGEL PHARMACEUTICALS INC | $18.72 | -4.29% | -1.78% | 9.15% | -11.53% | 31.83% | 71.74% | -23.90% | 9.47% | -58.49% | $29.82 | $7.48 | 37.22% | 150.13% | 1.37 | 151,966 | 3.40% |
| RPRX | ROYALTY PHARMA PLC | $32.48 | -1.04% | 1.40% | 4.20% | 3.67% | 19.85% | 15.71% | -23.31% | N/A | N/A | $34.20 | $24.05 | 5.03% | 35.05% | 0.53 | 2,605,651 | -42.68% |
| NVO | NOVO NORDISK A S | $65.60 | -1.28% | 4.74% | -3.57% | -20.63% | -41.40% | -49.23% | 15.25% | 106.84% | 129.53% | $148.15 | $57.00 | 55.72% | 15.09% | 0.57 | 16,257,075 | 75.89% |
| ADMA | ADMA BIOLOGICS INC | $23.27 | -2.23% | 4.21% | 19.82% | 41.29% | 20.13% | 248.88% | 1,131.22% | 673.09% | 180.13% | $25.67 | $6.65 | 9.35% | 249.92% | 1.06 | 2,780,813 | -1.31% |
| INCY | INCYTE CORP | $62.03 | -1.01% | 5.19% | 1.84% | -15.88% | -18.52% | 17.17% | -18.44% | -36.25% | -36.88% | $83.95 | $52.73 | 26.11% | 17.64% | 0.57 | 2,438,897 | -13.59% |
| MDXG | MIMEDX GROUP INC | $6.32 | -8.14% | -7.06% | -15.73% | -26.00% | -8.80% | -13.54% | 60.00% | N/A | -31.53% | $10.14 | $5.47 | 37.67% | 15.54% | 1.22 | 1,510,254 | 114.40% |
| MNKD | MANNKIND CORP | $4.95 | -1.79% | 6.00% | 0.00% | -11.13% | -30.96% | 14.06% | 50.91% | 296.00% | -76.32% | $7.63 | $4.17 | 35.12% | 18.85% | 1.10 | 1,480,761 | -26.29% |
| VCYT | VERACYTE INC | $29.71 | -2.59% | -7.56% | 0.51% | -34.07% | -13.41% | 47.59% | 37.61% | 13.53% | 231.22% | $47.32 | $19.73 | 37.21% | 50.58% | 1.92 | 1,276,109 | 19.15% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $62.71 | -1.54% | -0.05% | -7.70% | 0.43% | -5.84% | -24.74% | -24.73% | -28.84% | -45.90% | $94.85 | $52.93 | 33.89% | 18.48% | 0.73 | 1,564,666 | 20.68% |
| GNFT | GENFIT SA | $4.08 | -0.37% | 11.17% | 15.78% | 5.97% | -30.61% | 18.64% | 13.33% | -81.34% | N/A | $6.42 | $2.55 | 36.48% | 60.00% | 0.36 | 8,254 | 178.76% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $117.18 | 0.19% | 7.52% | -6.25% | -3.93% | 6.09% | 6.23% | -25.51% | 6.93% | -35.17% | $148.06 | $95.49 | 20.85% | 22.71% | 0.71 | 1,286,249 | 14.11% |
| TECH | BIO-TECHNE CORP | $49.63 | -1.43% | -2.26% | -13.46% | -31.12% | -34.10% | -32.44% | -48.11% | -12.75% | 105.23% | $85.57 | $46.01 | 42.00% | 7.87% | 1.13 | 1,609,235 | 5.18% |
| ACAD | ACADIA PHARMACEUTICALS INC | $14.57 | -0.21% | -1.75% | -10.72% | -21.29% | -1.62% | -14.55% | -25.44% | -67.57% | -59.15% | $20.68 | $13.40 | 29.55% | 8.73% | 0.88 | 1,432,957 | -23.09% |
| GMAB | GENMAB A | $20.93 | -1.04% | 1.90% | 12.17% | 9.52% | -7.23% | -27.20% | -39.87% | -16.28% | 172.60% | $30.41 | $17.24 | 31.17% | 21.44% | 0.72 | 1,263,895 | -6.69% |
| UTHR | UNITED THERAPEUTICS CORP | $293.85 | -3.05% | -0.87% | -4.25% | -17.13% | -21.43% | 15.17% | 63.41% | 169.29% | 71.92% | $417.82 | $255.93 | 29.67% | 14.82% | 0.49 | 426,972 | -45.60% |
| REGN | REGENERON PHARMACEUTICALS INC | $590.00 | -1.46% | -1.63% | -4.38% | -11.52% | -30.06% | -34.70% | -9.51% | 12.27% | 25.22% | $1.21k | $525.99 | 51.29% | 12.17% | 0.59 | 1,189,030 | -29.21% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.